Deck Bio and ReTrax Therapeutics Awarded 2025 Bristol Myers Squibb Golden Tickets

Seeking Alpha / 1 Views

Winners receive $50,000 credit to LabCentral's flagship site CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- LabCentral today announced that Deck Bio and ReTrax Therapeutics were awarded LabCentral Golden Tickets sponsored by Bristol Myers Squibb (BMS). The prizes were awarded on October...

Comments